Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review – 2015 Now Available at iData Insights Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct s, Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015 , provides an overview of the Kyorin Pharmaceutical Co., Ltd. s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kyorin Pharmaceutical Co., Ltd. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Kyorin Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Kyorin Pharmaceutical Co., Ltd. s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Kyorin Pharmaceutical Co., Ltd. s pipeline products Reasons to buy - Evaluate Kyorin Pharmaceutical Co., Ltd. s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Kyorin Pharmaceutical Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Kyorin Pharmaceutical Co., Ltd. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Kyorin Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kyorin Pharmaceutical Co., Ltd. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Kyorin Pharmaceutical Co., Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-
page.php?id=124195/kyorin-pharmaceutical-co-ltd-product-pipeline-review-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-
page.php?id=124195/kyorin-pharmaceutical-co-ltd-product-pipeline-review-2015 Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Kyorin Pharmaceutical Co., Ltd. Snapshot 6 Kyorin Pharmaceutical Co., Ltd. Overview 6 Key Information
1
6 Key Facts 6 Kyorin Pharmaceutical Co., Ltd.
Research and Development Overview
7 Key Therapeutic Areas 7 Kyorin Pharmaceutical Co., Ltd.
Pipeline Review
10 Pipeline Products by Stage of Development 10 Pipeline Products
Monotherapy
11 Pipeline Products
Combination Treatment Modalities
12 Pipeline Products
Partnered Products
13 Partnered Products/Combination Treatment Modalities 14 Kyorin Pharmaceutical Co., Ltd.
Pipeline Products Glance
15 Kyorin Pharmaceutical Co., Ltd.
Late Stage Pipeline Products
15 Phase III Products/Combination Treatment Modalities 15 Kyorin Pharmaceutical Co., Ltd.
Clinical Stage Pipeline Products
16 Phase II Products/Combination Treatment Modalities 16 Kyorin Pharmaceutical Co., Ltd.
Early Stage Pipeline Products
17 IND/CTA Filed Products/Combination Treatment Modalities 17 Preclinical Products/Combination Treatment Modalities 18 Discovery Products/Combination Treatment Modalities 19 Kyorin Pharmaceutical Co., Ltd.
Drug Profiles
20 (aclidinium bromide + formoterol fumarate) 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 KRPAM-1977X 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 vibegron 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 ibudilast 24 Product Description
2
24 Mechanism of Action 24 R&D Progress 24 KRP-203 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 KRPAM-1977Y 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 neramexane mesylate 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 tipelukast 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 AX-11890 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 AX-13057 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 KCA-1490 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Small Molecule to Inhibit PDE4 for Inflammation 36 Product Description 36 Mechanism of Action
3
36 R&D Progress 36 MN-002 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Kyorin Pharmaceutical Co., Ltd.
Pipeline Analysis
38 Kyorin Pharmaceutical Co., Ltd.
Pipeline Products by Target
38 Kyorin Pharmaceutical Co., Ltd.
Pipeline Products by Route of Administration
40 Kyorin Pharmaceutical Co., Ltd.
Pipeline Products by Molecule Type
41 Kyorin Pharmaceutical Co., Ltd.
Pipeline Products by Mechanism of Action
42 Kyorin Pharmaceutical Co., Ltd.
Recent Pipeline Updates
43 Kyorin Pharmaceutical Co., Ltd.
Dormant Projects
54 Kyorin Pharmaceutical Co., Ltd.
Discontinued Pipeline Products
55 Discontinued Pipeline Product Profiles 55 KRP-110 55 tipelukast 55 Kyorin Pharmaceutical Co., Ltd.
Locations And Subsidiaries
56 Head Office 56 Other Locations & Subsidiaries 56 Appendix 59 Methodology 59 Coverage 59 Secondary Research 59 Primary Research 59 Expert Panel Validation 59 Contact Us 59 Disclaimer Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124195/kyorin-
pharmaceutical-co-ltd-product-pipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
4
Contact Us: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
5